Rearming the body’s immune system to fight cancer

We’re developing more precise and more accessible treatment alternatives for patients with solid cancers

The future of cancer treatment – combining stem cells and immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.

Learn more about us

Some of our partners

Latest news

Congratulations to Cartherics CEO

By carth_admin / April 1, 2022
Alan Trounson is ranked among the world’s most prominent scientists
Read More

Cartherics CEO discusses the importance of industry-academic collaboration with new partner

By carth_admin / March 30, 2022
In the following interview with ARMI Alan Trounson discusses the importance and challenges of translation
Read More

7th Innate Killer Summit 2022, Dr Nicholas Boyd Presenting

By Karen Loudon / March 25, 2022
7th Innate Killer Summit (San Diego, California) Cartherics Chief Development Officer, Dr Nicholas Boyd The innate cell therapy field is...
Read More